[Precision oncology from a proteogenomics perspective].

Cancer is a heterogeneous disease with complex mechanisms that requires targeted precision medicine strategies. This review describes the limitations of genomic analysis and highlights the importance of proteogenomics to re-understand precision oncology from a proteogenomic perspective.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 The growth of precision medicine is indispensable from the rapid development of genomics.
• 2 However, genomics has certain limitations in molecular phenotype analysis, proteogenomics thus arose at the right time.
• 3 Proteogenomics is the merging of proteomics and genomics.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: